This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (44)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MAURICE J. COSTELLO, M.D.; ORLANDO CANIZARES, M.D.; MEREDITH MONTAGUE III, M.D.; CONSTANCE MILLETTE BUNCKE, M.D.

AMA Arch Derm. 1955;71(5):605-614.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1845 Virchow was the first to describe under the term "Weisses Blut or Leukaemie" a syndrome characterized by splenomegaly and a considerable increase in the white blood corpuscles.^* In 1891 Ehrlich was able to separate the myeloid proliferations from the lymphatic ones and gave a hematological basis to this differentiation. The first cutaneous manifestation of leukemia was recorded by Biesiadecki in 1876 Later in 1902, Audry suggested the term "leucémides" to describe the nonspecific cutaneous manifestations of leukemia.³

Leukemia cutis of the lymphogenous variety being much more frequent than the myelogenous one, it is not surprising to note that all of the first case reports were those of lymphogenous leukemia. The first cases of myelogenous cutaneous leukemia were reported by Hindenberg⁴ and Hirschlaff in 1895, and in 1899 by Nekam.⁶

CLASSIFICATION

The cutaneous manifestations of myelogenous leukemia can . . . [Full Text PDF of this Article]

Author Affiliations
New York

From Lenox Hill Hospital.

Footnotes
Read before the 74th Annual Meeting of the American Dermatological Association, Inc., White Sulphur Springs, W. Va., April 17, 1954.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?